Linical

Right Size. Right Reach. Right Team. We are a global Contract Research Organization (CRO) for full-service drug development.

Let us support your journey, the right way. Linical is a public, mid-sized Contract Research Organization headquartered in Japan with a significant presence across North America, Europe, and Asia-Pacific. Linical provides the full spectrum of drug development services from early stage to large-scale, multinational studies. Our areas of focus include Phase I-IV studies in oncology, infectious disease, and CNS. Rather than be all things to the market, this intentional design allows us to provide our clients the right size, right reach, and right team. At Linical, we are the trusted, global CRO to deliver innovative solutions for even the most complex industry challenges. We provide our clients with the personal attention, flexibility, and reach needed for a continually evolving pharmaceutical and biotech market. We believe in supporting clients throughout their unique clinical development journey, with a shared goal of bringing promising new therapies to patients all over the world. Linical’s vision is to be the CRO of choice amongst the global, mid-sized CRO market. We will achieve this by continuing to expand our current geographical reach into additional parts of the world, enabling us to thoughtfully partner with our clients anywhere their clinical development endeavors take them. While strategically growing our business, we are committed to maintaining the personal, attentive service our clients, employees, and patients deserve.

03/24/2026

New blog article now live! In our latest article, Julie Rosenberg, MD highlights a critical and concerning trend: the rising incidence of early-onset colorectal cancer (CRC) in individuals under 50. Once considered a disease affecting older adults, CRC is impacting younger populations, making awareness, early detection, and proactiveness more important than ever.

March is Colorectal Cancer Awareness Month, a month which highlights the importance of early screening, recognizing symptoms, and increasing awareness. In this article, Dr Rosenberg talks about risk factors and etiology, as well as genetic factors and lifestyle considerations. Read more to understand the risks, prevention methods, and treatment options>> https://hubs.la/Q04847D00

03/19/2026

We spoke to Lara Lopez, Director, Project Management as she recently celebrated 20 years of working at Linical. We discussed Lara's proudest moment, the ways in which Linical has changed, and the future direction of clinical trials. Read more >> https://hubs.la/Q047hmk80

03/17/2026

March is Multiple Myeloma Awareness Month, a campaign aimed at raising awareness of the second most common blood cancer that affects more than 176,000 people worldwide each year (https://hubs.la/Q0474J1_0). In our latest blog article, Julie Rosenberg, MD discusses current treatment approaches for newly diagnosed multiple myeloma, and reviews contemporary management strategies for patients with recently diagnosed disease. Read our latest blog article and learn more about Linical's expertise in multiple myeloma >> https://hubs.la/Q0474xGs0

03/12/2026

New blog article now live! Hear from Alaina Dobos, Senior Clinical Trial Manager at Linical as she looks at how 2026 marks a pivotal year in multiple sclerosis research.

Alaina discusses how advances in disease biology, immune mechanisms, and biomarker discovery are reshaping therapeutic development and clinical trial design and highlights the key priorities for CROs and sponsors alike. Read More >> https://hubs.la/Q046xFMQ0

03/10/2026

Are you in New York today and tomorrow attending Medidata NEXT?

Our Director of Business Development, Bill Scully is attending and would love to connect. If you're attending, drop us a message to arrange a meeting and discover how Linical can help accelerate your clinical trial success >> https://hubs.la/Q0469yKd0

03/08/2026

Today we are proudly celebrating International Women's Day and would like to pay a huge thanks to our amazing, hardworking and dedicated team members across the globe, who are driving progress in clinical research.

This years theme is . By giving opportunities and celebrating the leadership, achievements and strength of women working worldwide to make a difference, together we are able to strengthen teams, advance research and help deliver life changing treatments to patients around the world.

A huge thank you to all the women working at Linical and wider clinical research community for all that you do!

03/04/2026

Will you be in New York next week to attend Medidata NEXT?

The event will bring industry leaders together across life sciences focusing on exploring AI that drives measurable impact in clinical research. There will be an opportunity to learn how AI powered solutions will help achieve better trial design, cut costs and make trials more efficient and patient centric.

Bill Scully, Director of Business Development will be there, and would love to meet up. Drop us a message to schedule a meeting https://hubs.la/Q045y-cz0

03/03/2026

April 2026 marks a change in clinical trial regulations in the United Kingdom, with the most significant reform taking place in nearly 20 years. The changes will see a shift towards a modern, digitally enabled landscape to meet the needs of the clinical trials industry. In this article Krzysztof Majkowski, Associate Director, Regulatory Affairs at Linical gives insight into the new framework focusing on participant safety, the combined review process, and discusses what this means for everyday regulatory practice. Read more>> https://hubs.la/Q045mGY20

02/26/2026

In our latest blog article, Emily Dickinson, Director Quality Assurance at Linical, discusses Root Cause Analysis (RCA) and Corrective and Preventive Actions (CAPA) in clinical research. The article looks at why RCA and CAPA are both important, some common pitfalls to avoid when conducting a RCA and some of the best tools to use within clinical research. Finally Emily discusses common mistakes to avoid as you work through your CAPA Process.

Read more>> https://hubs.la/Q044Sd850

02/19/2026

Thierry Ingrand, Sr Director Business Development at Linical has worked for some of the world's largest Contract Research Organizations (CROs). In this article he talks about the common misconception that 'bigger is always better' and highlights the benefits of mid-sized CROs when selecting the right clinical partner for your study. Thierry gives five key considerations for selecting your next CRO and talks about the importance of finding a balance between scale, focus, and commitment.

Read more and discover why Linical has the right size, right reach and right team for your next study>> https://hubs.la/Q043PPfW0

02/17/2026

Each clinical trial is unique and can often face challenges, however some challenges can signal that your trial may be at risk.

Is it time to consider a rescue strategy and what should you look for to identify a new CRO partner? In this article, Linical discusses the key signs to look out for as well as outlining questions to ask your new CRO partner, to ensure your trial delivers the outcome it deserves.

Read more>> https://hubs.la/Q043kJtP0

Address

789 SW Federal Highway
Stuart, FL
34994

Telephone

+15614211443

Website

https://www.linical.com/

Alerts

Be the first to know and let us send you an email when Linical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Linical:

Shortcuts

Want your practice to be the top-listed Clinic in Stuart?